Stay updated on Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial
Sign up to get notified when there's something new on the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page.

Latest updates to the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page
- ChecktodayChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check7 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check14 days agoChange DetectedThe study record page displays a 403 Forbidden message with a Home link instead of study information.SummaryDifference0.5%

- Check28 days agoChange DetectedAccess to the NCT02614066 study page now displays a 403 Forbidden error, replacing the usual trial details with an error screen. This indicates a site access issue rather than an update to the study content.SummaryDifference21%

- Check50 days agoChange DetectedA 2015 NIH grant/contract funding note was added to the study page, and the revision history now shows v3.6.6 with the previous v3.6.5 entry removed.SummaryDifference0.1%

- Check71 days agoChange DetectedThe page’s document revision has been updated from v3.6.4 to v3.6.5, indicating a newer version of the referenced material. This reflects an administrative update to the document version rather than a change to study details or outcomes.SummaryDifference0.0%

Stay in the know with updates to Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brexucabtagene Autoleucel in B-precursor ALL Clinical Trial page.